Skip to Content

EKIMAS Corp ASNB

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

EKIMAS Corp, formerly AdvanSource Biomaterials Corp is a United States-based materials technology company specializing in medical grade materials for long and short term applications. Its technology includes ChronoFlex, ChronoSilTM, HydroMed, and HydroThane. The company's product portfolio includes polycarbonate based urethanes, polyther based materials, hydrophilic materials, elastomeric materials, and others. Also, the group provides services like customized materials, customer solutions, product extensions, project management, and others.

Contact
229 Andover Street
Wilmington, MA, 01887
T +1 978 657-0075
Sector Healthcare
Industry Medical Instruments & Supplies
Most Recent Earnings Dec 31, 2019
Fiscal Year End Mar 31, 2020
Stock Type Slow Growth
Employees 11